Pneumocystis Pneumonia and Acute Kidney Injury Induced by Everolimus Treatment in a Patient with Metastatic Breast Cancer
Everolimus, an inhibitor of the rapamycin pathway, is administered with the combination of an aromatase inhibitor for the treatment of metastatic estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancers. Interstitial lung disease is a well-known maj...
Main Authors: | Mayuko Nakamura, Ryoichi Matsunuma, Kei Yamaguchi, Ryosuke Hayami, Michiko Tsuneizumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2020-02-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/505909 |
Similar Items
-
Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer
by: Kelvin Teck-Hong Kuik, et al.
Published: (2014-10-01) -
Pneumocystis Jirovecii Pneumonia in a Kidney Transplant Recipient 13 Months after Transplantation: A Case Report and Literature Review
by: Dominykas Varnas, et al.
Published: (2021-01-01) -
Pneumocystis pneumonia in patients with Hodgkin lymphoma
by: T N Moiseeva, et al.
Published: (2014-11-01) -
Non-HIV <it>Pneumocystis</it> pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?
by: Asai Nobuhiro, et al.
Published: (2012-06-01) -
Current Epidemiology of Pneumocystis Pneumonia
by: Alison Morris, et al.
Published: (2004-10-01)